Nicoletta Colombo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chemo Plus Tecentriq Shows Improvements in Endometrial Carcinoma

A phase 3 trial demonstrated progression-free survival improvements with Tecentriq-chemotherapy combination in patients with endometrial carcinoma.

Sri lankaEuropean institute of oncologyNational cancer instituteNicoletta colomboEuropean instituteGynecologic cancer

Atezolizumab Improves PFS in Advanced Endometrial Cancer

Adding atezolizumab to chemotherapy improved PFS in a phase 3 trial of patients with advanced, newly diagnosed or recurrent endometrial cancer.

Sri lankaEuropean institute of oncologyNicoletta colomboEuropean institute

More Data Support Adding Immunotherapy to Chemo in Advanced Endometrial Cancer

PFS doubled and OS improved, driven by mismatch repair-deficient disease

Sri lankaCharles bankheadEuropean society for medical oncologyNational university cancer institute of singaporeEuropean institute of oncologyNicoletta colomboEuropean instituteEuropean societyMedical oncologyCancer genome atlasNational university cancer instituteMedpage today

Double Good, Triple Therapy Better in Endometrial Cancer?

The fast pace of progress in endometrial cancer has taken a step forward with two trials underlining the benefit of immunotherapy plus chemo, while suggesting adding a PARP inhibitor could further boost outcomes.

United statesFriuli venezia giuliaSri lankaGenentech rocheNuvation bioShannon westinMerck seronoUniversity of valenciaBoehringer ingelheimNational university cancer instituteJazz pharmaceuticalsEuropean society for medical oncologyMd anderson cancer centerUniversity of milanMario negri institute for pharmacological researchEuropean society

Corcept Therapeutics (CORT) Announces Journal of Clinical Oncology Publishes Results of Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer

Corcept Therapeutics (CORT) Announces Journal of Clinical Oncology Publishes Results of Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDevelopment officerCorcept therapeutics incorporatedOvarian cancer centerAmerican society of clinical oncologyUniversity of milanProgram of gynecologyEuropean institute of oncologyClinical oncologyAmerican societyPlatinum resistant ovarian cancerOpen label phaseNicoletta colomboAssociate professorEuropean instituteBill guyer